Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Insulin pen
by Most Market Reports in the Switzerland in 2018

The Insulin pen top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Market Reports Insulin pen Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. It was introduced and marketed as NovoPen by the Danish company Novo Nordisk in 1985.
#
Company Name
Region
Tech Topics
Total
1
F. Hoffmann-La Roche Ltd.
Medicine,Health care,Drug,
...[+2]
market report: 15
2
Ypsomed Holding AG
Medical equipment,Pen needles,Self-medication,
...[+2]
market report: 11
3
Ascensia Diabetes Care Holdings AG
Blood glucose monitoring,Medical equipment,Health care,
...[+2]
market report: 5
4
Roche Holding AG
Drug,Clinical chemistry,Medicine,
...[+2]
market report: 3
5
Novartis AG
Dosage form,Health care,Medicine,
...[+2]
market report: 2
Page generation time: Jul 05 2025